Pernetrexed (P) plus carboplatin (Cb) as 1st treatment for patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC): Results of both a multi-center European and an MD Anderson Cancer Center (MDACC) phase II trials

  1. Lookup NU author(s)
  2. Dr Graham Dark
  3. Angela Price
Author(s)Zinner R, Kortsik C, Dark G, Price A, Manegold C, Rosell R, Paz-Ares L, Herbst R, Crino L, Scagliotti G
Publication type Conference Proceedings (inc. Abstract)
Conference NameLung Cancer: 11th World Conference on Lung Cancer
Conference LocationBarcelona, Spain
Year of Conference2005
Legacy Date3-6 July 2005
Volume49 (s2)
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherElsevier Ireland Ltd
Actions    Link to this publication
Library holdingsSearch Newcastle University Library for this item